Dr. Knowles is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
101 Manning Dr
Chapel Hill, NC 27514Phone+1 919-966-4996Fax+1 919-843-5515
Education & Training
- Duke University HospitalResidency, Internal Medicine, 1973 - 1975
- Ohio State University HospitalResidency, Internal Medicine, 1971 - 1973
- University of North Carolina at Chapel Hill School of MedicineClass of 1971
Certifications & Licensure
- NC State Medical License 1971 - 2023
- MD State Medical License 1975 - 1978
- OH State Medical License 1972 - 1974
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- Gene Modifiers of Cystic Fibrosis Lung Disease Start of enrollment: 2001 Sep 01
- Rare Genetic Disorders of the Breathing Airways Start of enrollment: 2006 May 01
- Genetic Modifiers of Cystic Fibrosis (CF) Liver Disease Start of enrollment: 2004 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- Promoter Deletion Leading to Allele Specific Expression in a Genetically Unsolved Case of Primary Ciliary Dyskinesia.M Makenzie Beaman, Weining Yin, Amanda J Smith, Patrick R Sears, Margaret W Leigh
American Journal of Medical Genetics. Part A. 2025-02-01 - Long G4-rich enhancers target promoters via a G4 DNA-based mechanism.Jeffrey D DeMeis, Justin T Roberts, Haley A Delcher, Noel L Godang, Alexander B Coley
Nucleic Acids Research. 2024-12-10 - Comparison of Longitudinal Outcomes in Children with Primary Ciliary Dyskinesia and Cystic Fibrosis.BreAnna Kinghorn, Margaret Rosenfeld, Erin Sullivan, Frankline M Onchiri, Marshall D Brown
Annals of the American Thoracic Society. 2024-12-01
Journal Articles
- Mutation of CFAP57, a Protein Required for the Asymmetric Targeting of a Subset of Inner Dynein Arms in Chlamydomonas, Causes Primary Ciliary DyskinesiaMichael Knowles, MD, PLOS Genetics
Authored Content
- Analysis of a Large Cohort of Cystic Fibrosis Patients with Severe Liver Disease Indicates Lung Function Decline Does Not Significantly Differ from That of the General Cystic Fibrosis PopulationOctober 2018
Press Mentions
- Consortium Spotlight: Advancing Discoveries in Mucociliary Clearance DiseasesMarch 11th, 2022
- Portlaoise Hospital's X-ray Team Hit the Mark in Health Watchdog's New ReviewJune 25th, 2020
- Help Is at Hand for Covid-19 Staff Stress Says Portlaoise Hospital ManagerApril 29th, 2020
- Join now to see all
Grant Support
- Pathogenesis Of PCD Lung DiseaseNational Heart, Lung, And Blood Institute2004–2012
- Genetic Disorder Of Mucocilary ClearanceNational Heart, Lung, And Blood Institute2009–2011
- Molecular Phenotypes For Cystic Fibrosis Lung DiseaseNational Heart, Lung, And Blood Institute2008–2011
- Gene Modifiers In CF Lung DiseaseNational Heart, Lung, And Blood Institute2001–2010
- Association Of Genotype And Circulating Levels Of Tgf?1 In Cystic Fibrosis PANational Center For Research Resources2008
- RARE Genetic Disorders Of The AirwaysNational Center For Research Resources2007–2008
- Genetic Modifiers Of CF Liver DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2008
- Genetic Mutations In Patients With Primary Ciliary Dyskinesia And FamilyNational Center For Research Resources2004–2008
- Genetic Disorders Of Mucociliary Clearance: RARE Diseases: Pcd, Cf, &PhaNational Center For Research Resources2004–2008
- Genetic Disorders Of Mucociliary ClearanceNational Center For Research Resources2004–2008
- Genetic Modifiers Of Inherited Liver DiseaseNational Center For Research Resources2007
- Gene Modifiers In Cystic Fibrosis Lung DiseaseNational Center For Research Resources2007
- Measurement Of Airway Transepithelial Potential Difference In CFNational Center For Research Resources2005–2007
- Multicenter Study Of Nontuberculous Mycobacteria In PTS With Cystic FibrosisNational Center For Research Resources1999–2002
- Airway Inflammation &Mediators In Chronic BronchitisNational Center For Research Resources1999–2002
- Airway Surface Liquid Composition Of Humans In VivoNational Heart, Lung, And Blood Institute1998–2002
- Measurement Of Airway Transepithelial Potential Difference In Cystic FibrosisNational Center For Research Resources1996–2002
- Nontuberculous Mycobacteria In PTS W/ Cystic FibrosisNational Center For Research Resources2000
- Glucocorticoids &Mineralocorticoids On Electrical Potential DifferenceNational Center For Research Resources2000
- CPX In Adult W/ Mild To Moderately Severe Cystic FibrosisNational Center For Research Resources2000
- Airway Transepithelial Potential Difference In CFNational Center For Research Resources2000
- Human Respiratory Epithelial Function In VivoNational Heart, Lung, And Blood Institute1995–2000
- Measurement Of Airway Electrical Potential DifferenceNational Center For Research Resources1996–1999
- Gene Transfer In Vivo In Cystic Fibrosis PatientsNational Heart, Lung, And Blood Institute1996–1997
- Gene Transfer In Cystic Fibrosis Using E1 Deleted AdenovirusNational Center For Research Resources1996–1997
- Acute Safety And Efficacy Of Aerosolized Nucleotides As Therapy For CFNational Center For Research Resources1995–1996
- Pharmacokinetics Of Amiloride Administration In Cyctic Fibrosis PatientsNational Center For Research Resources1995
- Acute Effects Of Aerosolized Amiloride In Cystic Fibrosis And Normal SubjectsNational Center For Research Resources1995
- Clinical Investigator AwardNational Heart, Lung, And Blood Institute1985
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: